Table: Rohto - 6-MTH group results

Rohto Pharmaceutical

10/11/2023 06:00

Nov 10 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2023        Sep 30, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              127.87              110.31           270.00    
                   (+15.9 pct)         (+21.2 pct)      (+13.1 pct) 
  Operating           20.97               16.27            38.50    
                   (+28.9 pct)         (+18.3 pct)      (+13.4 pct) 
  Recurring           22.68               17.96            40.00    
                   (+26.2 pct)         (+33.1 pct)      (+12.5 pct) 
  Net                 16.59               13.19            29.00    
                   (+25.8 pct)         (+19.7 pct)      (+9.9 pct)  
  EPS               72.74 yen           57.83 yen       127.12 yen  
  EPS Diluted       72.53 yen           57.66 yen                   
  Ann Div                                                27.00 yen  
  -Q2 div           12.00 yen           20.00 yen                   
  -Q4 div                               12.00 yen        15.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T